Physician profile
John Christopher James
NPI 1023233368
$2,132.10
in general payments reported to CMS, 2019-2025
8 companies · $22.41 in 2025
The $22.41 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $240 · 2021: $1,190 · 2022: $503 · 2023: $61.81 · 2025: $22.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,044.72 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $458.16 | 2019-2023 | Phasix Mesh |
| Sanara Medtech INC. | $209.43 | 2022 | |
| Acell, INC. | $139.59 | 2019-2020 | |
| Endogastric Solutions, INC | $115.40 | 2020 | |
| Smith+Nephew, INC. | $114.35 | 2019-2023 | Collagenase Santyl |
| Organogenesis INC. | $37.36 | 2023-2025 | Apligraf, Puraply |
| Innocoll Pharmaceuticals Limited | $13.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.